218 related articles for article (PubMed ID: 35522143)
1. Multimodality Imaging for Cardiotoxicity: State of the Art and Future Perspectives.
Artico J; Abiodun A; Shiwani H; Kurdi H; Chen D; Tyebally S; Moon JC; Westwood M; Manisty CH
J Cardiovasc Pharmacol; 2022 Oct; 80(4):547-561. PubMed ID: 35522143
[TBL] [Abstract][Full Text] [Related]
2. The Role of Cardiovascular Magnetic Resonance for Surveillance of Cardiac Performance upon Receipt of Potentially Cardiotoxic Cancer Therapeutics.
Parashar A; Hundley WG
Curr Cardiol Rep; 2018 Oct; 20(12):142. PubMed ID: 30367282
[TBL] [Abstract][Full Text] [Related]
3. The Growing Impact of Cardiovascular Oncology: Epidemiology and Pathophysiology.
Tufano A; Coppola A; Galderisi M
Semin Thromb Hemost; 2021 Nov; 47(8):899-906. PubMed ID: 34255338
[TBL] [Abstract][Full Text] [Related]
4. [Cardiotoxicity of anticancer therapies. Towards the implementation of cardio-oncology units].
Hameau R; Gabrielli L; Garrido M; Guzmán AM; Retamal I; Vacarezza MJ; Greig D; Ocqueteau M; Sánchez C; Pizarro M; Corvalán A; Lavandero S; Castro PF; Martínez G
Rev Med Chil; 2018 Jan; 146(1):68-77. PubMed ID: 29806680
[TBL] [Abstract][Full Text] [Related]
5. Multimodality assessment and treatment of chemotherapy-induced cardiotoxicity.
Storozynsky E
Future Cardiol; 2015 Jul; 11(4):421-4. PubMed ID: 26238563
[No Abstract] [Full Text] [Related]
6. Cardiovascular Toxicity and Risk Mitigation with Lung Cancer Treatment.
Yegya-Raman N; Berlin E; Feigenberg SJ; Ky B; Sun L
Curr Oncol Rep; 2023 May; 25(5):433-444. PubMed ID: 36811807
[TBL] [Abstract][Full Text] [Related]
7. Cardiooncology-dealing with modern drug treatment, long-term complications, and cancer survivorship.
de Wall C; Bauersachs J; Berliner D
Clin Exp Metastasis; 2021 Aug; 38(4):361-371. PubMed ID: 34117981
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular Imaging in Cardio-Oncology: The Role of Echocardiography and Cardiac MRI in Modern Cardio-Oncology.
Gambril JA; Chum A; Goyal A; Ruz P; Mikrut K; Simonetti O; Dholiya H; Patel B; Addison D
Heart Fail Clin; 2022 Jul; 18(3):455-478. PubMed ID: 35718419
[TBL] [Abstract][Full Text] [Related]
9. Advanced imaging modalities to detect cardiotoxicity.
Awadalla M; Hassan MZO; Alvi RM; Neilan TG
Curr Probl Cancer; 2018 Jul; 42(4):386-396. PubMed ID: 30297038
[TBL] [Abstract][Full Text] [Related]
10. Management and research in cancer treatment-related cardiovascular toxicity: Challenges and perspectives.
Cautela J; Lalevée N; Ammar C; Ederhy S; Peyrol M; Debourdeau P; Serin D; Le Dolley Y; Michel N; Orabona M; Barraud J; Laine M; Bonello L; Paganelli F; Barlési F; Thuny F
Int J Cardiol; 2016 Dec; 224():366-375. PubMed ID: 27673693
[TBL] [Abstract][Full Text] [Related]
11. Cardio-oncology Part I: chemotherapy and cardiovascular toxicity.
O'Hare M; Sharma A; Murphy K; Mookadam F; Lee H
Expert Rev Cardiovasc Ther; 2015 May; 13(5):511-8. PubMed ID: 25843285
[TBL] [Abstract][Full Text] [Related]
12. Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management.
Curigliano G; Cardinale D; Dent S; Criscitiello C; Aseyev O; Lenihan D; Cipolla CM
CA Cancer J Clin; 2016 Jul; 66(4):309-25. PubMed ID: 26919165
[TBL] [Abstract][Full Text] [Related]
13. Identifying cancer patients at risk for cardiotoxicity.
Salvatici M; Sandri MT
Future Oncol; 2015; 11(14):2077-91. PubMed ID: 26198838
[TBL] [Abstract][Full Text] [Related]
14. State of the art for cardiotoxicity due to chemotherapy and to targeted therapies: a literature review.
Berardi R; Caramanti M; Savini A; Chiorrini S; Pierantoni C; Onofri A; Ballatore Z; De Lisa M; Mazzanti P; Cascinu S
Crit Rev Oncol Hematol; 2013 Oct; 88(1):75-86. PubMed ID: 23522920
[TBL] [Abstract][Full Text] [Related]
15. Cancer Therapeutics-Related Cardiovascular Complications. Mechanisms, Diagnosis and Treatment.
Oikonomou E; Anastasiou Μ; Siasos G; Androulakis E; Psyrri A; Toutouzas K; Tousoulis D
Curr Pharm Des; 2018; 24(37):4424-4435. PubMed ID: 30636595
[TBL] [Abstract][Full Text] [Related]
16. Established and Emerging Cancer Therapies and Cardiovascular System: Focus on Hypertension-Mechanisms and Mitigation.
Butel-Simoes LE; Haw TJ; Williams T; Sritharan S; Gadre P; Herrmann SM; Herrmann J; Ngo DTM; Sverdlov AL
Hypertension; 2023 Apr; 80(4):685-710. PubMed ID: 36756872
[TBL] [Abstract][Full Text] [Related]
17. Cardiotoxicity screening of long-term, breast cancer survivors-The CAROLE (Cardiac-Related Oncologic Late Effects) Study.
Puckett LL; Saba SG; Henry S; Rosen S; Rooney E; Filosa SL; Gilbo P; Pappas K; Laxer A; Eacobacci K; Kapyur AN; Robeny J; Musial S; Chaudhry A; Chaudhry R; Lesser ML; Riegel A; Ramoutarpersaud S; Rahmani N; Shah A; Papas V; Dawodu T; Charlton J; Knisely JPS; Lee L
Cancer Med; 2021 Aug; 10(15):5051-5061. PubMed ID: 34245128
[TBL] [Abstract][Full Text] [Related]
18. Advances in Multimodality Imaging in Cardio-Oncology: JACC State-of-the-Art Review.
Baldassarre LA; Ganatra S; Lopez-Mattei J; Yang EH; Zaha VG; Wong TC; Ayoub C; DeCara JM; Dent S; Deswal A; Ghosh AK; Henry M; Khemka A; Leja M; Rudski L; Villarraga HR; Liu JE; Barac A; Scherrer-Crosbie M;
J Am Coll Cardiol; 2022 Oct; 80(16):1560-1578. PubMed ID: 36229093
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive review on cardio-oncology: Role of multimodality imaging.
Chen-Scarabelli C; McRee C; Leesar MA; Hage FG; Scarabelli TM
J Nucl Cardiol; 2017 Jun; 24(3):906-935. PubMed ID: 27225513
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular imaging in the diagnosis and monitoring of cardiotoxicity: cardiovascular magnetic resonance and nuclear cardiology.
Pepe A; Pizzino F; Gargiulo P; Perrone-Filardi P; Cadeddu C; Mele D; Monte I; Novo G; Zito C; Di Bella G
J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1():S45-54. PubMed ID: 27183525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
